Cargando…

Co‐occurrence of CDKN2A/B and IFN‐I homozygous deletions correlates with an immunosuppressive phenotype and poor prognosis in lung adenocarcinoma

Homozygous deletion (HD) of CDKN2A and CDKN2B (CDKN2A/B (HD)) is the most frequent copy‐number variation (CNV) in lung adenocarcinoma (LUAD). CDKN2A/B (HD) has been associated with poor outcomes in LUAD; however, the mechanisms of its prognostic effect remain unknown. We analyzed genome, transcripto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Yuan, Chen, Yonghong, Song, Mengmeng, Zhang, Xiaoyue, Li, Pansong, Yu, Xian, Huang, Yusheng, Zhang, Ni, Ji, Liyan, Xia, Lei, Xia, Xuefeng, Yi, Xin, Tan, Benxu, Yang, Zhenzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019898/ https://www.ncbi.nlm.nih.gov/pubmed/35253368 http://dx.doi.org/10.1002/1878-0261.13206

Ejemplares similares

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
por: Sievers, Philipp, et al.
Publicado: (2020)

CDKN2A/B Homozygous Deletions in Astrocytomas: A Literature Review
por: Yuile, Alexander, et al.
Publicado: (2023)

Impact of CDKN2A/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma
por: Huang, L. Eric
Publicado: (2022)

Frequent homozygous deletion of Cdkn2a/2b in tremolite‐induced malignant mesothelioma in rats
por: Okazaki, Yasumasa, et al.
Publicado: (2020)

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma
por: Funakoshi, Yusuke, et al.
Publicado: (2021)

MPC-10 Prognostic analysis in IDH mutant astrocytoma patient with CDKN2A/B homozygous deletion
por: Yanagisawa, Shunsuke, et al.
Publicado: (2021)

Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
por: Tang, Vivian, et al.
Publicado: (2023)

P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas
por: Vij, Meenakshi, et al.
Publicado: (2023)

Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis
por: Huang, Yusheng, et al.
Publicado: (2022)

Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy
por: Grard, Marion, et al.
Publicado: (2021)

SDPS-27 P16 IMMUNOHISTOCHEMISTRY AS A SCREENING TOOL FOR HOMOZYGOUS CDKN2A DELETIONS IN GLIAL TUMORS
por: Zschernack, Valentina, et al.
Publicado: (2023)

An unusual recurrent high-grade glioneuronal tumor with MAP2K1 mutation and CDKN2A/B homozygous deletion
por: Cheaney, Barry, et al.
Publicado: (2019)

Homozygous deletion of CDKN2A by fluorescence in situ hybridization is prognostic in grade 4, but not grade 2 or 3, IDH-mutant astrocytomas
por: Marker, Daniel F., et al.
Publicado: (2020)

Exercise Enhanced Cardiac Function in Mice With Radiation-Induced Heart Disease via the FNDC5/Irisin-Dependent Mitochondrial Turnover Pathway
por: He, Wuyang, et al.
Publicado: (2021)

Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
por: Maelandsmo, G. M., et al.
Publicado: (1995)

CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
por: Tu, Q, et al.
Publicado: (2018)

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: Four cases of homozygous deletions of the CDKN2A gene
por: Carén, Helena, et al.
Publicado: (2008)

Genomic Profiling Reveals Synchronous Bilateral Lung Adenocarcinomas With Distinct Driver Alterations of EML4-ALK or TPM3-ROS1 Fusion: A Case Report
por: Tan, Benxu, et al.
Publicado: (2019)

Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis
por: Ortiz, Berenice, et al.
Publicado: (2014)

CDKN2A Deletion Leading to Hematogenous Metastasis of Human Gastric Carcinoma
por: Qiao, Juanli, et al.
Publicado: (2021)

Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free Survival
por: Barresi, Valeria, et al.
Publicado: (2021)

Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study
por: Park, Yae Won, et al.
Publicado: (2023)

HGG-08. COMBINATORIAL ACTIVITY OF CDK4/6-INHIBITORS AND TRAMETINIB IN PEDIATRIC HIGH-GRADE GLIOMA WITH BRAFV600E MUTATION AND HOMOZYGOUS CDKN2A DELETION
por: Mayr, Lisa, et al.
Publicado: (2023)

Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)

CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients
por: Xu, Na, et al.
Publicado: (2015)

Homozygous deletion of Tenascin-R in a patient with intellectual disability
por: Dufresne, David, et al.
Publicado: (2012)

Homozygous deletion in MICU1 presenting with fatigue and lethargy in childhood
por: Lewis-Smith, David, et al.
Publicado: (2016)

The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma
por: Lesueur, F, et al.
Publicado: (2008)

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies
por: Münch, Johannes, et al.
Publicado: (2017)

Amplified and Homozygously Deleted Genes in Glioblastoma: Impact on Gene Expression Levels
por: Crespo, Inês, et al.
Publicado: (2012)

FNBtools: A Software to Identify Homozygous Lesions in Deletion Mutant Populations
por: Sun, Liang, et al.
Publicado: (2018)

Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma
por: Snuderl, Matija, et al.
Publicado: (2018)

Intragenic Homozygous Deletions of MTS1 Gene in Gastric Cancer in Taiwan
por: Wu, Ming‐Shiang, et al.
Publicado: (1996)

Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine
por: Barekatain, Yasaman, et al.
Publicado: (2021)

Cross talk between glucose metabolism and immunosuppression in IFN-γ–primed mesenchymal stem cells
por: Yao, Mengwei, et al.
Publicado: (2022)

Tumor immune microenvironment and mutational analysis of tracheal adenoid cystic carcinoma
por: Wang, Fei, et al.
Publicado: (2020)

Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas
por: Kocakavuk, Emre, et al.
Publicado: (2023)

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
por: Genescà, E., et al.
Publicado: (2018)

Childhood Acute B-Lineage Lymphoblastic Leukemia With CDKN2A/B Deletion Is a Distinct Entity With Adverse Genetic Features and Poor Clinical Outcomes
por: Feng, Jing, et al.
Publicado: (2022)

Detection of somatic copy number deletion of the CDKN2A gene by quantitative multiplex PCR for clinical practice
por: Tian, Yuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_damjjjp5j5ln07ig8nt0bop9ps